Cas:73268-46-9 ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate manufacturer & supplier

We serve Chemical Name:ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate CAS:73268-46-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate

Chemical Name:ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate
CAS.NO:73268-46-9
Synonyms:2H-1,4-Benzoxazine-2-carboxylicacid,3,4-dihydro-7-methyl-,ethyl ester;2-ethoxycarbonyl-7-methyl-3,4-dihydro-2H-1,4-benzoxazine
Molecular Formula:C12H15NO3
Molecular Weight:221.25200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:47.56000
Exact Mass:221.10500
LogP:1.86900

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2H-1,4-Benzoxazine-2-carboxylicacid,3,4-dihydro-7-methyl-,ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-ethoxycarbonyl-7-methyl-3,4-dihydro-2H-1,4-benzoxazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-ethoxycarbonyl-7-methyl-3,4-dihydro-2H-1,4-benzoxazine Use and application,2-ethoxycarbonyl-7-methyl-3,4-dihydro-2H-1,4-benzoxazine technical grade,usp/ep/jp grade.


Related News: Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms. ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate manufacturer With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate supplier Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate vendor Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms. ethyl 7-methyl-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate factory Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.